To assess the patient's capability of performing a correct skin-check examination we investigated the association of melanoma detection pattern with Breslow thickness, by melanoma body area. In this prospective observational study, patients with primary cutaneous melanoma who presented at the Department of Dermatology at the University of Florence between January 2000 and November 2011 were interviewed as part of their clinical data recording procedure at the time of their final histopathological diagnoses of melanoma. With the aim of evaluating a self skin-check, we included patients with melanoma in the anterior part of the trunk (abdomen and chest area), which is generally considered visible in the mirror, and the posterior part of the trunk, which is a more complex area to be self-checked. The treating physician specifically questioned all patients about who had first detected or suspected the lesion that resulted in the histological diagnosis of melanoma in order to compare those who had self-detected (SD) their melanoma with those who had discovered their melanoma during a regular skin-check (RSC) with a dermatologist. A total of 186 melanoma patients were analyzed, with 67% (n = 125) of melanomas located on the back and 33% (n = 61) in the chest and abdominal area; the majority (55%, n = 103) were in the SD group. The median Breslow thickness of the SD group was significantly greater than that of the RSC group: 0.60 versus 0.50 mm (P < 0.0001). In the posterior trunk, the frequency of thick melanomas (Breslow ≥ 1.00 mm) was significantly greater in the SD group than in the RSC group (34 vs. 11%; P = 0.003), whereas there was no difference in the frequency of thick melanoma by detection patterns in the anterior trunk. Given the influence of the body area in detecting threatening melanoma, we should encourage people to obtain dermatological skin-checks more often. Skin selfexaminations cannot be sufficiently accurate.
Introduction
Unlike many neoplasms, a melanoma is clearly visible on the outer surface of the skin, even in the early stages of the disease (radial growth). When found at an early stage, melanoma has one of the highest cure rates of all cancers at more than 90%; thus, theoretically, if the general population learns to recognize a suspicious lesion, the mortality rate for melanoma should rapidly decline. Likewise, an adequate skin self-examination (SSE) has great potential as a noninvasive, quick, and cost-effective detection strategy for melanoma; however, random trials have not established its efficacy, nor are there trials likely to be conducted because of ethical, cost, and time limitations (US Preventive Services Task Force, 2009). Messages such as 'the changing mole', 'the ABCDE rule', 'the Ugly Duckling Sign', and surveillance programs such as 'open clinic days for skin cancer screening', introduced in the 1980s, had the goal of instructing patients to perform regular SSE and to recognize suspicious lesions on the skin, with particular emphasis on high-risk groups. Obviously, these detection strategies have not reached their aim because the mortality for melanoma remains the same (Criscione and Weinstock, 2010; National Cancer Institute; Surveillance, Epidemiology, and End Results (SEER) Program, 2010).
The current literature shows that patients who selfdetected (SD) their lesions through SSE have significantly thicker melanomas than those who detected their melanomas during regular skin-checks (RSCs) with a dermatologist (Brady et al., 2000; Schwartz et al., 2002; Kovalyshyn et al., 2011; De Giorgi et al., 2012) . The reason for this is probably related to the fact that dermatologists, in addition to their experience and professional training, now have access to a number of technological devices such as dermatoscopy, total body photography, and confocal microscopy, which allow them to identify suspect lesions in the very early stages.
The explanation for why SSE has only partially helped the fight against melanoma is not yet clear, but one of the most important problems seems to be linked to the incomplete self-detection that patients have generally applied. In fact, not all skin surface areas where melanomas can appear are easily visible to a patient. A survey of American residents showed that only 9% of them performed an appropriate SSE, as defined by the researchers, for different reasons including the difficulties in self-detecting in quite a few body areas (Weinstock et al., 1999) . The main predictors of a thorough SSE are having been advised to do so by a physician, availability of a partner to help, and availability of a wall and handheld mirror (Rigel et al., 2010) . Moreover, another important issue seems to be the fact that the highest risk population with a low level of instruction, generally men over 50 years, does not receive the messages from educational campaigns (Youl et al., 2011) . We conducted the present study with the aim to better understand the impact of melanoma body area on SSE.
Patients and methods
All patients with a diagnosis of primary cutaneous melanoma who came to the Department of Dermatology at the University of Florence between January 2000 and December 2011 were interviewed as part of their clinical data recording procedure at the time of their final histopathological diagnoses. During the interviews, we asked the patients about their age, education level, and family or personal history of melanoma. The patients included in the study were evaluated to assess the association with the locations on the body where the melanoma was found, as well as their Breslow thickness and the detection pattern.
With the aims outlined above, we divided the body surface into two areas that are generally considered visible or not visible in the mirror: the anterior part of the trunk (abdomen and chest area) and the posterior part of the trunk. Taking into consideration the goal of the present study, we excluded from our analysis patients who had melanomas located in partially visible parts of the body, such as the head and neck, legs, arms, genital area, and the sole and palm areas.
In addition, the treating physician specifically questioned all patients about who had first detected or suspected the lesion that had resulted in the histological diagnosis of melanoma to identify those who had SD their melanoma and those who had discovered their melanoma during a RSC with a dermatologist. In accordance with the aim of the present study, we excluded patients who had discovered the melanoma with the help of a general practitioner, a family member, or others.
The biopsy specimens were reviewed by the dermatopathologists of the University of Florence for confirmation of the histopathological diagnosis and for a measurement of the tumor's thickness.
Statistical analysis
Descriptive statistics (frequencies, median, and interquartile ranges) are presented for patient characteristics. χ 2 -Tests were performed to assess differences by thickness (considering Breslow ≥ 1 mm). Multivariate ANCOVA models were used to assess the associations of different detection modalities with Breslow thickness, adjusting for confounders (age, sex, family history, education). Breslow is transformed to reach normality of residuals of fully adjusted models. Multivariate logistic models were adopted to investigate the association of detection patterns with the melanoma's thickness (Breslow ≥ 1 mm). We reported two-sided P-values. Data were analyzed using the SAS System Software (release 8.0; SAS Institute, Cary, North Carolina, USA) for Windows.
Results
Starting with a group of 866 melanoma patients who were initially interviewed, we included in the present analysis 186 patients with cutaneous melanoma who fit our criteria (SD or discovered their melanoma during a RSC by a dermatologist). In-situ melanoma was not considered.
In Table 1 , we present personal characteristics of the included patients by Breslow thickness. Only few had a personal history (8%) or family history of melanoma (12%). The majority had a high level of education (57%). Significantly older patients (age > 51years) were found in thin melanoma (Breslow < 1) than in thicker melanoma (56 vs. 36%; P = 0.02) cases. The majority of melanomas were located on the patients' backs (n = 125, 67%) and were detected by SD (55%). Between detection patterns considered, the frequency of SD was found to be significantly greater in thick melanomas (Breslow > 1) than in thin ones: 74 vs. 50% (P = 0.006). Eighty-six percent of all patients had a superficial spreading melanoma. The other characteristics were not significantly different between thin and thick melanomas.
As regards Breslow thickness of melanomas in the two patient categories (SD vs. RSC), we found that the median Breslow thickness of the SD group was significantly higher than the median Breslow thickness of the RSC group (0.60 vs. 0.50 mm; P < 0.0001), adjusting for potential confounding variables (e.g. age, sex, family history, body site, and education) ( Table 2) .
Multivariate logistic models suggest that the frequency of thick melanomas on the posterior trunk is significantly (P = 0.003) greater with SD (34%) than with RSC (11%), adjusting for sex, age, family history, and education (Table 3 ). In contrast, on the anterior trunk the frequency of thick melanoma in the RSC group is very similar to that of the SD group (P = 0.48).
Discussion
The results of our study clearly show that the Breslow thickness of the RSC group's melanoma was much thinner than that of the SD group. This result is consistent with the majority of the papers published in this regard (Brady et al., 2000; Schwartz et al., 2002; Kovalyshyn et al., 2011; De Giorgi et al., 2012) . This difference remains detectable if we compare the RSC group and the SD group with respect to the posterior and anterior parts of the body. In particular, it is important to underline that the frequency of thick melanomas on the patients' posterior trunks was significantly greater in SD patients (23%) than in RSC patients (7%), even adjusting for major risk factors. These data could be linked to the fact that thin lesions are clinically very similar to regular moles, and the hope that a patient can recognize and suspect small lesions is quite unreasonable, especially because even expert dermatologists have difficulty clinically diagnosing thin melanomas.
Looking at the differences in the melanomas' locations in the SD group, we can state that the chest and abdominal areas had a much smaller median Breslow thickness compared with the other areas. This result is certainly related to the fact that the chest and abdominal areas are most visible to the patients. Furthermore, our findings were confirmed after adjusting for age, that is, a significant confounding variable, as younger age at the time of diagnosis was associated with significantly lower melanoma thickness in several studies (Ambrosini-Spaltro et al., 2014; Cadby et al., 2014; Haenssle et al., 2014) .
Our results seem to be obvious; however, to our knowledge, this is the first published study whose primary focus is the relationship between body areas and melanoma self-detection.
Therefore, on the basis of the present study, we believe that the message of SSEs should to be considerably modified to decrease the overall mortality from cutaneous melanoma. In fact, as we pointed out, a SSE does not allow patients to discover cutaneous melanoma in its early stage, and some body locations, such as the back, are not detectable even with the help of a mirror. For the aforementioned reasons, we are convinced that new, modified instructions should be given to the entire population to encourage them to undergo an annual skin examination and stress its importance among those considered high-risk patients, such as uneducated men over 50 years of age. In addition, during the period outside the annual dermatological examination, we would like to encourage patients to conduct melanoma self-detections, keeping in mind that a part of the skin surface is partially invisible and that for a correct, total skin examination they need to seek the help of somebody, such as a partner, a family member, or their general practitioner. (79) 23 (82) 
